Global /South Korea /Healthcare /Drug Manufacturers - General /044820
chevron_leftBack
Cosmax BTI, Inc. logo

Cosmax BTI, Inc.

044820
KRX: 044820 Delayed
17,810KRW 0.1%
11.80 USD
As of 18 June 2026, Cosmax BTI, Inc. has a market cap of $111.5M USD, ranking #24760 globally and #1156 in South Korea. It ranks #2213 in the Healthcare sector, and #798 in the Drug Manufacturers - General industry.
Global Rank
24760
Country Rank
1156
Sector Rank
2213
Industry Rank
798
Key Stats
Market Cap
$111.5MUSD
170.08B KRW
Enterprise Value
$395.52MUSD
596.99B KRW
Revenue (TTM)
$423.0MUSD
645.21B KRW
EBITDA (TTM)
$36.14MUSD
54.54B KRW
Net Income (TTM)
$19.15MUSD
29.21B KRW
EBITDA Margin
8.5%
Profit Margin
4.5%
PE Ratio
5.8
PS Ratio
0.3
PB Ratio
0.6
EV/EBITDA
7.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
1984
Website
cosmaxbti.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.1% 1.4% 9.9% 36% 20% 58%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
044820
코스맥스비티아이(주)
ISIN: KR7044820009
Shares Out.:
9.555M1 Shares Float: 2.846M2
TV:
SA:
YF:
GF:
BA:
MS:
17,810 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cosmax BTI, Inc.

Cosmax BTI, Inc. engages in the research, development, production, and sale of cosmetics, health functional foods, pharmaceuticals, and special containers in South Korea. The company offers cosmetics products, including skincare, mask, cleansing, hair, bath and body, sun care, makeup, cushion, eye and lip makeup, nail, and fragrance products; baby and child cosmetic products; Korean herbal cosmetics; and cosmeceuticals. It also provides health supplement products in form of gels, capsules, and powders; and medical devices. In addition, the company exports its products. Cosmax BTI, Inc. was founded in 1984 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.12B
13.91T KRW
8K%
-
$6.75B
10.3T KRW
6K%
1958.1
$5.23B
7.97T KRW
5K%
29.9
298380
$4.95B
7.55T KRW
4K%
-
000100
$4.54B
6.92T KRW
4K%
35.9
$4.43B
6.76T KRW
4K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
683K%
38.1
JNJ
$547.28B
491K%
26.4
ABBV
$360.63B
323K%
97.4
$323.08B
256.25B CHF
290K%
19.9
AZN
$289.5B
215.59B GBP
260K%
27.6
NOVN
$275.99B
218.9B CHF
247K%
20.5
chevron_leftBack